PL4322772T3 - Zastosowanie środka kontrolującego uwalnianie w kompozycji nikotyny - Google Patents

Zastosowanie środka kontrolującego uwalnianie w kompozycji nikotyny

Info

Publication number
PL4322772T3
PL4322772T3 PL22715985.2T PL22715985T PL4322772T3 PL 4322772 T3 PL4322772 T3 PL 4322772T3 PL 22715985 T PL22715985 T PL 22715985T PL 4322772 T3 PL4322772 T3 PL 4322772T3
Authority
PL
Poland
Prior art keywords
control agent
release control
nicotine composition
nicotine
composition
Prior art date
Application number
PL22715985.2T
Other languages
English (en)
Inventor
Ara ABRAHAMIAN
Vahid NOURI
Original Assignee
Habit Factory In Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Habit Factory In Sweden Ab filed Critical Habit Factory In Sweden Ab
Publication of PL4322772T3 publication Critical patent/PL4322772T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/12—Chemical features of tobacco products or tobacco substitutes of reconstituted tobacco
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/165—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes comprising as heat source a carbon fuel or an oxidized or thermally degraded carbonaceous fuel, e.g. carbohydrates, cellulosic material
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/365—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having nitrogen and sulfur as hetero atoms in the same ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F23/00—Cases for tobacco, snuff, or chewing tobacco
    • A24F23/02—Tobacco pouches

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
PL22715985.2T 2022-03-15 2022-03-15 Zastosowanie środka kontrolującego uwalnianie w kompozycji nikotyny PL4322772T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22715985.2A EP4322772B1 (en) 2022-03-15 2022-03-15 Use of a release control agent in a nicotine composition
PCT/EP2022/056762 WO2023174523A1 (en) 2022-03-15 2022-03-15 Nicotine composition

Publications (1)

Publication Number Publication Date
PL4322772T3 true PL4322772T3 (pl) 2025-03-10

Family

ID=81306767

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22715985.2T PL4322772T3 (pl) 2022-03-15 2022-03-15 Zastosowanie środka kontrolującego uwalnianie w kompozycji nikotyny

Country Status (9)

Country Link
US (1) US20250194662A1 (pl)
EP (2) EP4322772B1 (pl)
JP (1) JP2025509580A (pl)
CA (1) CA3245742A1 (pl)
ES (1) ES3010302T3 (pl)
HU (1) HUE070143T2 (pl)
MX (1) MX2024011331A (pl)
PL (1) PL4322772T3 (pl)
WO (1) WO2023174523A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230049343A1 (en) * 2021-07-30 2023-02-16 Nicoventures Trading Limited Shaped pouched products

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8469036B2 (en) * 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US9402809B2 (en) * 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition
ES2658166T3 (es) 2009-03-13 2018-03-08 Excellent Tech Products I Sverige Ab Producto para administración oral
WO2010114445A1 (en) 2009-04-03 2010-10-07 X-International Aps Plant fiber product and method for its manufacture
KR20200135809A (ko) * 2018-04-06 2020-12-03 필립모리스 프로덕츠 에스.에이. 니코틴 겔
US20210195937A1 (en) * 2018-11-05 2021-07-01 Blesst Boyz LLC Composition for a tobacco-free chew with liquid synthetic nicotine
WO2020207735A1 (en) * 2019-04-08 2020-10-15 Philip Morris Products S.A. Aerosol-generating film
EP3979841B1 (en) * 2019-06-05 2023-04-19 Philip Morris Products S.A. Nicotine composition, method for making and aerosol generating articles comprising such
DK3773494T3 (da) * 2019-06-07 2022-05-02 Ncp Nextgen As Nikotinposesammensætning og pose dermed
BR112022012308A2 (pt) * 2019-12-23 2022-09-06 Nutra Essential Otc S L Composição farmacêutica líquida para administração oral na forma de suspensão e seu processo de preparação

Also Published As

Publication number Publication date
HUE070143T2 (hu) 2025-05-28
JP2025509580A (ja) 2025-04-11
EP4322772B1 (en) 2024-10-30
EP4322772C0 (en) 2024-10-30
ES3010302T3 (en) 2025-04-02
EP4527213A2 (en) 2025-03-26
EP4322772A1 (en) 2024-02-21
WO2023174523A1 (en) 2023-09-21
MX2024011331A (es) 2025-03-07
CA3245742A1 (en) 2023-09-21
US20250194662A1 (en) 2025-06-19
EP4527213A3 (en) 2025-06-11

Similar Documents

Publication Publication Date Title
SG11202106478UA (en) Compositions for increasing half-life of a therapeutic agent in canines and methods of use
IL192545A (en) Use of 2mg / cm2 / min dispersed citrate iron to make a drug for the treatment of soft tissue calcification and pharmaceutical preparations containing this citrate iron
PL4322772T3 (pl) Zastosowanie środka kontrolującego uwalnianie w kompozycji nikotyny
GB2613260B (en) Supported nicotine composition
IL205320A0 (en) Compositions comprising an electrochemically altered fluid and a therapeutic agent and use thereof for treating lung or respiratory diseases
GB2610721B (en) Compositions for treating and combatting tuberculosis
GB202106282D0 (en) Composition and use thereof
WO2009057138A3 (en) Controlled release pharmaceutical compositions of tolterodine
EP4396316C0 (en) HYGIENIC COMPOSITION TO REDUCE BAD ODORS
ZA200809640B (en) Composition for fire fighting and formulations of said composition
HUE062897T2 (hu) Új késleltetett felszabadulású készítmény szájon át történõ beadáshoz
ZA202007392B (en) Concrete release agent and preparation method therefor
IL306046A (en) A preparation for use in the treatment of disorders related to MHC-1
PL4183857T3 (pl) Zastosowanie kompozycji smarnego środka uwalniającego
KR102457454B9 (ko) 이형 코팅 조성물
EP4353330A4 (en) AEROSOL FIRE EXTINGUISHER COMPOSITION
PL4106822T3 (pl) Kompozycja zawierająca mikrokapsułkowany środek neutralizujący nieprzyjemne zapachy i jej zastosowanie do redukcji nieprzyjemnych zapachów
ZA202212221B (en) A therapeutic composition
GB202315094D0 (en) Fungicidal agent and composition
GB202018838D0 (en) Composition for use in treatment of a biofilm in a subject
GB202306057D0 (en) A composition for anti-microbial use
GB202205340D0 (en) A composition for anti-microbial use
GB202008285D0 (en) Methods and compositions for treating and combatting tuberculosis
WO2009130712A3 (en) Controlled release pharmaceutical compositions of trospium
GB202505991D0 (en) A composition for anti-microbial use